Role of In Vitro Release Methods in Liposomal Formulation Development: Challenges and Regulatory Perspective
- 18 September 2017
- journal article
- review article
- Published by Springer Science and Business Media LLC in The AAPS Journal
- Vol. 19 (6), 1669-1681
- https://doi.org/10.1208/s12248-017-0142-0
Abstract
In the past few years, measurement of drug release from pharmaceutical dosage forms has been a focus of extensive research because the release profile obtained in vitro can give an indication of the drug’s performance in vivo. Currently, there are no compendial in vitro release methods designed for liposomes owing to a range of experimental challenges, which has created a major hurdle for both development and regulatory acceptance of liposome-based drug products. In this paper, we review the current techniques that are most often used to assess in vitro drug release from liposomal products; these include the membrane diffusion techniques (dialysis, reverse dialysis, fractional dialysis, and microdialysis), the sample-and-separate approach, the in situ method, the continuous flow, and the modified United States Pharmacopeia methods (USP I and USP IV). We discuss the principles behind each of the methods and the criteria that assist in choosing the most appropriate method for studying drug release from a liposomal formulation. Also, we have included information concerning the current regulatory requirements for liposomal drug products in the United States and in Europe. In light of increasing costs of preclinical and clinical trials, applying a reliable in vitro release method could serve as a proxy to expensive in vivo bioavailability studies.Keywords
This publication has 83 references indexed in Scilit:
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie, 2012
- Hyperthermia-triggered intracellular delivery of anticancer agent to HER2+ cells by HER2-specific affibody (ZHER2-GS-Cys)-conjugated thermosensitive liposomes (HER2+ affisomes)Journal of Controlled Release, 2011
- A novel class of photo-triggerable liposomes containing DPPC:DC8,9PC as vehicles for delivery of doxorubcin to cellsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Targeted Liposomal Drug Delivery to Monocytes and MacrophagesJournal of Drug Delivery, 2010
- The antimicrobial efficacy of sustained release silver–carbene complex-loaded l-tyrosine polyphosphate nanoparticles: Characterization, in vitro and in vivo studiesBiomaterials, 2009
- Quantification of structural properties of cell-sized individual liposomes by flow cytometryJournal of Bioscience and Bioengineering, 2006
- Immunogenicity and Safety of a Virosomal Hepatitis A Vaccine (Epaxal®) in the ElderlyJournal of Travel Medicine, 2006
- Klinische Wirksamkeit und Ausblicke für die Anwendung von pegyliertem liposomalem Doxorubicin bei der Behandlung von Ovarial- und MammakarzinomenDrugs, 1997
- Potential use of albumin microspheres as a drug delivery system. I. Preparation and in vitro release of steroidsInternational Journal of Pharmaceutics, 1987
- Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981